MYCOF
Noveris Health Sciences Inc. is a biotechnology company, which engages in the research, drug development, and clinical trials of psilocybin products. The company was founded by Parente Carman, Damon Michaels, and Robert Roscow on September 27, 2013 and is headquartered in Vancouver, Canada.
| Period | EPS | Revenue | FCF |
|---|---|---|---|
| 2026 Q1 | -0.10 | $0 | -$284,522 |
| 2025 Q4 | 2.56 | $0 | — |
| 2025 Q3 | 0.06 | $0 | — |
| 2025 Q2 | -0.00 | $0 | -$9,598 |
| 2025 Q1 | -0.00 | $0 | $9,507 |
| 2024 Q4 | 0.04 | $0 | -$59,848 |
| 2024 Q3 | -0.03 | $0 | $46,568 |
| 2024 Q2 | -0.04 | $0 | -$6,746 |